Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer

Montefiore Medical Center, The Bronx

Seoul National University Bundang Hospital, Seongnam-si

UPMC Magee-Womens Hospital, Pittsburgh

University of Maryland, Baltimore

Gachon University Gil Medical Center, Incheon

Virginia Cancer Specialists, Fairfax

Hospital Universitario Ramn y Cajal, Madrid

Hospital Universitario HM Sanchinarro, Madrid

NEXT Oncology, Madrid

MUSC, Charleston

Baptist Medical Center, Jacksonville

FCS - North, St. Petersburg

FCS - South, Fort Myers

Hematology Oncology Assoc of the Treasure Coast, Port Saint Lucie

Tennessee Oncology, Nashville

Cleveland Clinic, Cleveland

Hospital Clinico Universitario de Valencia, Valencia

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis

University of Wisconsin, Madison

Allina Health System, Minneapolis

University of Chicago Medical Center, Chicago

Nebraska Cancer Specialists, Omaha

UT Health East Texas HOPE Cancer Center, Tyler

Hematology Oncology Clinic, Baton Rouge

Rocky Mountain Cancer Centers, Lone Tree

Huntsman Cancer Institute Research, Salt Lake City

Los Angeles Hematology Oncology Medical, Los Angeles

USC Norris Cancer Center, Los Angeles

UCLA David Geffen, Santa Monica

Moores Cancer Center, La Jolla

Summit Cancer Centers, Spokane

MGH, Boston

DRCI, Boston

Soon Chun Hyang University Cheonan Hospital SCHMC, Cheonan

Korea University Anam Hospital, Seoul

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Samsung Medical Center, Seoul

Hospital Clinic i Provincial de Barcelona, Barcelona

Vall d'Hebron University Hospital, Barcelona

Institut Catala Oncologia, Barcelona

Hospital Parc Tauli, Sabadell